Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rameis

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1985
Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?H Rameis
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Cerebral cognitive deficits today]H Rameis
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Internal medicine aspects and characteristics of nutrition in patients with cerebral cognitive deficits]H Rameis
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists]H Rameis
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
The importance of prospective planning of pharmacokinetic trials. Considerations of studies on the phenytoin-digoxin-(P-D) and phenytoin-digitoxin-(P-DT) interactionH Rameis
Wiener Medizinische Wochenschrift (1946)|January 1, 1992
[The status of H2-blocker therapy today]H Rameis
Wiener Klinische Wochenschrift|April 13, 1984
[New drugs registered in Austria. Selectol]H Rameis
European Journal of Clinical Pharmacology|January 1, 1985
On the interaction between phenytoin and digoxinH Rameis
Wiener Medizinische Wochenschrift (1946)|March 31, 1983
[Characteristics of drug therapy in kidney and liver insufficiency, in infancy and old age, during pregnancy and lactation]H Rameis
Wiener Medizinische Wochenschrift (1946)|April 15, 1988
[Studies of biological availability. A critical assessment based on a study of spironolactone preparations]H Rameis, S Bacher
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1985
Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?H Rameis
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Cerebral cognitive deficits today]H Rameis
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Internal medicine aspects and characteristics of nutrition in patients with cerebral cognitive deficits]H Rameis
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists]H Rameis
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
The importance of prospective planning of pharmacokinetic trials. Considerations of studies on the phenytoin-digoxin-(P-D) and phenytoin-digitoxin-(P-DT) interactionH Rameis
Wiener Medizinische Wochenschrift (1946)|January 1, 1992
[The status of H2-blocker therapy today]H Rameis
Wiener Klinische Wochenschrift|April 13, 1984
[New drugs registered in Austria. Selectol]H Rameis
European Journal of Clinical Pharmacology|January 1, 1985
On the interaction between phenytoin and digoxinH Rameis
Wiener Medizinische Wochenschrift (1946)|March 31, 1983
[Characteristics of drug therapy in kidney and liver insufficiency, in infancy and old age, during pregnancy and lactation]H Rameis
Wiener Medizinische Wochenschrift (1946)|April 15, 1988
[Studies of biological availability. A critical assessment based on a study of spironolactone preparations]H Rameis, S Bacher
Pageof 5